4CPS-367 Impact of pharmaceutical consultation implementation on pharmaceutical interventions and the role of pharmacists in multidisciplinary teams

Background and importance Our hospital serves a population of 278 000, and we have, on average, 1500 monthly patient visits for drug dispensing. The pharmacists, working in this context, are responsible for activities such as analysing the patient’s pharmacotherapeutic profile, prescribing drug dosages, identifying possible interactions between different drugs or natural products/foods, confirming the indication of the prescription and alerting to possible drug adverse effects. This process may originate more than one pharmaceutical intervention (PI). Since we implemented the pharmaceutical consultation (PC) in 2015, pharmacists have become specialists for specific pathologies (starting with hepatitis C) and are closely monitoring their patients. Currently, PCs have been expanded to HIV, oncology, neurology, biological drugs, among others. Although drug dispensation is still the main source of PIs, PCs plays an increasing crucial role. Aim and objectives To characterise the PIs performed in the outpatient setting as an indicator of the PCs implemented. Material and methods A retrospective analysis of PI data was conducted in the context of outpatient drug dispensation, from January 2017 to August 2020. Results From January 2017 to August 2020, 3149 PIs were registered in 1453 patients. PIs have been growing annually as a result of PC implementation: 186 until 2017 (3 PC); 901 in 2018 (6 PC); 943 in 2019 (9 PC); and this year we have already done 2017. The infectious diseases specialty had the highest number of PIs (31%), followed by ophthalmology (26%), gastroenterology (17%), oncology (10%), biological drugs (7%), neurology (5%) and others (4%). Of all of the PIs, 61% were about compliance, 19% were about appointments and laboratory analysis, 4% related to missing medication prescriptions, 3% were about excessive duration of medications, notification of adverse drug reactions and drug interactions, 2% were related to changing the dose and 1% were due to therapeutic duplication and referral to the emergency department. From all PIs, 96% were accepted with modification (AwM–prescription/behaviour modified as suggested), 3% were accepted without modification (AoM–intervention accepted but with justified prescription/behaviour maintenance) and 1% were not accepted. Conclusion and relevance As seen previously, the number of PIs has been increasing over time, which is in part justified by the implementation of PCs. Having 96% of PIs AwM clearly shows the pharmacist’s impact, as part of the multidisciplinary team, in terms of patient compliance, quality of life and outcomes. References and/or acknowledgements Conflict of interest No conflict of interest